With InvestorVision™, a growing real estate firm slashed manual effort by 50 percent, streamlined K-1 distribution, and elevated the investor experience for over 30 stakeholders.
At the final Capital for Cures spring summit in Frankfurt, biotech founders and investors explored how to close expectation gaps, build trust and secure sustainable funding in a volatile market.